MedPath
HSA Approval

PRELONE SYRUP 3 mg/5 ml

SIN04845P

PRELONE SYRUP 3 mg/5 ml

PRELONE SYRUP 3 mg/5 ml

June 29, 1990

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

H02AB06

prednisolone

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PTE LTD

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

PREDNISOLONE

3 mg/5 ml

Prednisolone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.